Kevin Acreman
About Kevin Acreman
Kevin Acreman serves as the Process Engineering Lead at Lyndra Therapeutics in Lexington, Massachusetts. He holds a Master's Degree in Engineering Design and Technology Commercialization and a Bachelor's Degree in Biomedical/Medical Engineering from the University of Alabama at Birmingham.
Current Role at Lyndra Therapeutics
Kevin Acreman serves as the Process Engineering Lead in the Manufacturing Science and Technology (Ms&T) department at Lyndra Therapeutics. He has held this position since 2021, contributing to the company's efforts in developing innovative drug delivery systems. His role involves overseeing process engineering initiatives and ensuring the efficiency of manufacturing processes at the company's facility in Lexington, Massachusetts.
Education and Expertise
Kevin Acreman earned a Master’s Degree in Engineering Design and Technology Commercialization from the University of Alabama at Birmingham, completing his studies from 2015 to 2016. Prior to this, he obtained a Bachelor’s Degree in Biomedical/Medical Engineering from the same institution, where he studied from 2011 to 2015. His educational background provides him with a solid foundation in engineering principles and technology commercialization.
Previous Experience at Evonik
Before joining Lyndra Therapeutics, Kevin Acreman worked at Evonik, where he began as an intern in 2016 for six months in Birmingham, Alabama. Following his internship, he progressed to the role of Senior Scientist, a position he held from 2016 to 2021. During his five years at Evonik, he gained valuable experience in the field of process engineering and scientific research.
Professional Background
Kevin Acreman's professional journey includes significant roles in process engineering and scientific research. His experience at Evonik and current position at Lyndra Therapeutics reflect his expertise in engineering and technology within the pharmaceutical sector. His background in biomedical engineering supports his contributions to the development of advanced drug delivery systems.